As whey prices climb and protein-powder supply tightens, Canadian startup Phytokana has locked in $330M in fava bean offtake deals — a sign of where the high-protein craze is heading next.
America's protein obsession has a supply problem. Whey prices are climbing, dairy-based protein powder is getting harder to source at scale, and food companies riding the high-protein wave are quietly looking for backup plans. One of those backup plans just got a $330 million vote of confidence, and it's made from fava beans.
Canadian ingredient company Phytokana has secured C$450M ($330M) in long-term offtake agreements for its fava bean protein products, according to Green Queen. The contracts span three to 10 years, involve both domestic and overseas buyers, and push total potential sales above $500M when additional memoranda of understanding are included.
The deals will underpin a commercial-scale dry fractionation facility in Strathmore, Alberta, capable of processing 30,000 tonnes of fava beans a year into protein concentrates and high-protein flours.
The conventional wisdom is that whey rules the protein aisle. Athletes drink it, snack bars are fortified with it, and the dairy supply chain has spent decades optimizing around it. But the math is shifting. Whey is a byproduct of cheese production, and as Food Dive has reported, surging consumer demand for high-protein everything is colliding with a supply that can't simply be willed into existence overnight.
That gap is where plant proteins are stepping in, not as ideological replacements, but as practical ones.
Phytokana's pitch is functional, not philosophical. Its fava protein concentrate clocks in at 70% protein and 12% dietary fibre, with what the company describes as a mild taste and strong emulsifying and gelation properties. Translation: it can go into meat alternatives, dairy analogs, breads, and bakery without dragging down flavor or texture. The fava bean flour contains 32-36% protein and 21% fibre, and a starch-rich variant runs 18-20% protein, useful for gluten-free and extruded products.
Phytokana founder and CEO Chris Theal said the long-term offtake agreements at this stage are a strong validation of both product performance and the company's commercial strategy.
Chairman Vincent Chahley framed the deals in financial terms, noting that the level of contracted demand significantly de-risks the path to commercialization and reinforces the strength of partnerships and long-term strategy.
The company, founded in 2021, sources its fava beans from Alberta's chernozemic soils and uses a heat- and chemical-free fractionation process. It is working with the University of Alberta on protein composition and taste across different fava genotypes, with the University of Manitoba on extrusion recipes, and has sponsored a plant-based milk project at the University of Guelph.
Who profits from the protein-shortage narrative? Mostly the companies positioned to fill it. The interesting question for everyone else is whether the current craze, from protein bars and protein chips to protein coffee and protein popcorn, is actually about nutrition, or about identity packaging. Either way, the ingredient stack underneath it is being rewritten in real time. Look at what's already on shelves: Barilla sells chickpea and red lentil pastas in mainstream grocery channels, while GoodMills Innovation has introduced a fava bean, yellow pea, sunflower seed, and wheat protein blend for baked goods. When companies built around familiar pantry staples start hedging into legumes, the shift isn't a niche trend anymore. It's a reformulation cycle. And a lot of it is going to come from beans most American shoppers couldn't pick out of a lineup.
That's a quieter story than a shortage headline, but probably a more durable one.
